TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case–control study
Open Access
- 22 May 2020
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 40 (5)
Abstract
TP53 is a tumor suppressor gene that regulates cell growth, apoptosis and DNA repair. Previous studies have reported the contribution of TP53 Arg72Pro (rs1042522 C>G) polymorphism to pathogenesis of multiple tumors. Hence, we evaluated the association between this polymorphism and neuroblastoma susceptibility in eastern Chinese children. The Taqman genotyping assay was performed in 373 patients and 762 controls. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the strength of the association. No significant association was found between the TP53 gene rs1042522 C>G polymorphism and neuroblastoma susceptibility in the overall analysis (CG vs. CC: adjusted OR = 0.92, 95% CI = 0.70–1.22, P=0.567; GG vs. CC: adjusted OR = 0.99, 95% CI = 0.69–1.42, P=0.947; CG/GG vs. CC: adjusted OR = 0.94, 95% CI = 0.72–1.23, P=0.639; or GG vs. CC/CG: adjusted OR = 1.04, 95% CI = 0.75–1.43, P=0.814) and stratified analysis by age, gender, sites of origin, and clinical stages. The TP53 gene rs1042522 C>G polymorphism may not be a risk factor for neuroblastoma in eastern Chinese children. Future studies are needed to confirm this negative result and to reveal additional functional TP53 variants predisposing to neuroblastoma.Keywords
This publication has 36 references indexed in Scilit:
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaNature Genetics, 2012
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility LociPLOS Genetics, 2011
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studiesThe Lancet Oncology, 2009
- Common variations in BARD1 influence susceptibility to high-risk neuroblastomaNature Genetics, 2009
- p53 mutations in human cholangiocarcinoma: a reviewLiver International, 2005
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- p53Cell, 2002
- p53-Mediated Apoptosis and Genomic Instability DiseasesActa Oncologica, 2001